We deliver GMP-compliant, process-oriented facility design specifically optimized for monoclonal antibody (mAb) manufacturing, covering upstream cell culture, downstream purification, formulation, and aseptic filling workflows. Fully aligned with FDA, EMA Annex 1, PIC/S and ISPE biomanufacturing standards, our design framework addresses the unique requirements of high-density mammalian cell culture, continuous perfusion operations, and high-purity protein purification, ensuring regulatory compliance, operational efficiency, and batch-to-batch consistency.
Our layout features functionally segregated production zones with strictly controlled unidirectional personnel and material flow systems to eliminate cross-contamination and mix-up risks. We adopt rational cleanroom grading and differential pressure cascade design for cell expansion, bioreactor processing, chromatography purification, ultrafiltration concentration, and sterile formulation areas. Dedicated utility systems including WFI, pure steam, CIP/SIP sanitary piping, and precision HVAC are fully optimized to support stable long-term mAb production.
Tailored for both traditional fed-batch and advanced continuous perfusion manufacturing processes, our facility design accommodates scalable production volumes from clinical pilot batches to large-scale commercial mAb manufacturing. We integrate lean engineering principles to streamline process workflows, minimize operational dead space, reduce energy consumption, and maximize facility utilization. All design outputs are risk-based and fully documented to support DQ/IQ/OQ validation and global regulatory audits.
Suitable for greenfield mAb production plants, modular bioprocess workshops, and GMP upgrades of existing antibody facilities, our professional design solutions effectively reduce post-construction modification costs, shorten project delivery cycles, and accelerate the launch of compliant monoclonal antibody products.
